Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $43.6 million.

  • Beta Bionics' Shares Outstanding (Weighted Average) rose 55511.68% to $43.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.6 million, marking a year-over-year increase of 55511.68%. This contributed to the annual value of $6.4 million for FY2024, which is 2001.21% up from last year.
  • Latest data reveals that Beta Bionics reported Shares Outstanding (Weighted Average) of $43.6 million as of Q3 2025, which was up 55511.68% from $43.4 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Shares Outstanding (Weighted Average) ranged from a high of $43.6 million in Q3 2025 and a low of $5.3 million during Q4 2023
  • Over the past 3 years, Beta Bionics' median Shares Outstanding (Weighted Average) value was $6.5 million (recorded in 2024), while the average stood at $18.5 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 2001.21% in 2024, then skyrocketed by 61064.5% in 2025.
  • Over the past 3 years, Beta Bionics' Shares Outstanding (Weighted Average) (Quarter) stood at $5.3 million in 2023, then increased by 20.01% to $6.4 million in 2024, then skyrocketed by 585.52% to $43.6 million in 2025.
  • Its last three reported values are $43.6 million in Q3 2025, $43.4 million for Q2 2025, and $30.7 million during Q1 2025.